Axbio
PrivateLast Round
Series B
May 27, 2022
Est. Valuation
$239M
Total Funding Raised
$118.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Axbio operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series B round in May 2022.
Axbio is a semiconductor-biotechnology company that develops next-generation electrochemical detection platforms, including nanopore sequencing and Bio-CMOS chip technology for molecular diagnostics and life science research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Semiconductors, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axbio Comparables
Compare Axbio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roswell Biotechnologies | 86% | |
| Ultima Genomics | 85% | |
| Element Biosciences | 84% |
For institutional investors. Book with your work email.
Axbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2022 | ||||
| Series A Extension | Oct 15, 2021 | ||||
| Series A | Aug 29, 2018 | ||||
| Seed | Oct 1, 2017 |
For institutional investors. Book with your work email.
Axbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Series A Extension |
| SDIC Innovation Investment Management | Series B |
| MSA Capital | Series A Extension |
| CBC Group | Series B |
| 5Y Capital | Series B, Series A Extension |
| Yunfeng Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 33% MoM, reaching 2.5K.
- Apr 16, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Axbio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axbio's valuation, stock price, and market status.
Is Axbio a public or private company?
Axbio is a private company.
What is the current stock price of Axbio?
Axbio is a private company, so its shares have no public market price. Caplight tracks Axbio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axbio worth (valuation)?
Axbio's valuation is estimated at $239.0M based on funding round data.
Can I buy Axbio stock?
Axbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axbio's last funding round?
Axbio's most recent funding round was Series B on May 27, 2022.
Who are the main investors in Axbio?
Key investors in Axbio include Kaitai Capital, MSA Capital, 5Y Capital, Yunfeng Capital.
Will Axbio IPO soon?
No public IPO plans have been announced for Axbio.
How can I track Axbio secondary market activity?
Caplight tracks bids, offers, and trades in Axbio's shares on secondary markets.